A suite of genome-engineered hepatic cells provide novel insights into the spatiotemporal metabolism of APOB and APOB-containing lipoprotein secretion.
Amber MeursKlevis NdojMarlene van den BergGoran MarinkovićMatteo TantucciTineke VeenendaalJan Albert KuivenhovenJudith KlumpermanNoam ZelcerPublished in: Cardiovascular research (2024)
In summary, the engineered cells reported here allow the study of hepatic VLDL assembly and secretion, and facilitate spatiotemporal interrogation induced by pharmacologic and genetic perturbations.